SOURCE: ISTA Pharmaceuticals

ISTA Pharmaceuticals

July 15, 2011 07:30 ET

ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2011 Financial Results

IRVINE, CA--(Marketwire - Jul 15, 2011) - ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced it will release second quarter 2011 financial results after the market closes on July 28, 2011. In conjunction, the Company will host a conference call at 4:30 p.m. Eastern Time to review the Company's commercial operations and provide pipeline updates.

Date: Thursday, July 28, 2011
Time: 4:30 p.m. Eastern Time

Conference call access:
Domestic dial-in: 866.804.6922
International dial-in: 857.350.1668
Passcode: 73568588

To access the 24-hour audio replay, U.S. and Canadian participants may dial 888.286.8010; international participants may dial 617.801.6888. The access code for the replay is 37743515. This conference call also will be webcast live and archived on ISTA's website until September 4, 2011.

About ISTA Pharmaceuticals
ISTA Pharmaceuticals, Inc. is a fast growing and the fourth largest branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies. Headquartered in Irvine, California, ISTA generated revenues of $156.5 million in 2010. For additional information about ISTA, please visit the corporate website at

Contact Information